期刊文献+

坏疽性脓皮病三例诊治分析 被引量:4

Pyoderma gangrenosum:a report of 3 cases
原文传递
导出
摘要 目的加强外科医生对坏疽性脓皮病的认识,避免误诊误治。方法回顾性分析10年来经外科治疗的3例坏疽性脓皮病的临床资料。结果 3例患者均表现为皮肤软组织坏死,形成潜行性疼痛性溃疡,伴发热;均按"感染"治疗,但创面分泌物多次培养阴性;各种抗生素治疗无效,积极清创换药而创面继续扩大,溃疡活检病理为非特异性炎症。诊断为坏疽性脓皮病后经全身糖皮质激素及免疫抑制剂治疗结合创面局部换药,病情均迅速得到控制并逐步缓解。结论坏疽性脓皮病易被误诊。确诊后病情重者应早期使用糖皮质激素和免疫抑制剂系统治疗,病情可迅速得到控制,创面经温和换药可自行愈合。 Objective To improve the surgeon's understanding of pyoderma gangrenosum (PG) and avoid misdiagnosis and incorrect treatment. Methods Three cases of PG managed in the department of general surgery during the past 10 years were retrospectively reviewed. Results All of the 3 cases mainly presented with necrosis of skin and soft tissues, followed by formation of painful and extensive creeping ulcer. They all had fever and were initially diagnosed and managed as " infection", but repeated wound exudates culture showed negative results and antimicrobial therapy was not effective. The ulcers were enlarged quickly despite of active debridement. Histopathology of ulcer biopsy suggested nonspecific inflarmnation. After the diagnosis of PG was established, systemic therapy with steroids and immunosuppressants were administered together with local wound care. The progress of the disease was controlled soon and fully resolved finally. Conclusions Pyoderma gangrenosum is misdiagnosed frequently. For severe patients, systemic therapy with steroids and immunosuppressants should be used as early as possible and skin lesions would heal together with mild local wound care.
出处 《中华外科杂志》 CAS CSCD 北大核心 2007年第21期1479-1481,共3页 Chinese Journal of Surgery
关键词 脓皮病 坏疽性 外科 诊断 治疗 Pyoderma gangrenosum Surgery Diagnosis Treatment
  • 相关文献

参考文献9

  • 1Waterworth AS, Horgan K. Pyoderma gangrenosum-an unusual differential diagnosis for acute infection. Breast, 2004,13: 250- 253.
  • 2Rozen SM, Nahabedian MY, Manson PN. Management strategies for pyoderma gangrenosum: case studies and review of literature. Ann Plast Surg,2001, 47: 310-315.
  • 3Callen J. Pyoderma gangrenosum. Lancet, 1998,351:581-585.
  • 4顾有守.坏疽性脓皮病[J].临床皮肤科杂志,2005,34(10):708-709. 被引量:42
  • 5Ahmadi S, Powell F. Pyoderma gangrenosum: presentations. Clin Dermatol, 2005,23:612-620.
  • 6Kiran RP, O' Brien-Ermlich B, Achkar JP. Management of peristomal pyoderma gangrenosum. Dis Colon Rectum, 2005,48: 1397-1403.
  • 7Reichrath J, Bens G, Bonowitz A, etal. Treatment recommondations for pyoderma gangrenosum: an evidence-based review of literature based on more than 350 patients. J Am Acad Dermatol, 2005,53:273-283.
  • 8李光明,孟祥军,周惠清,胡颍,李定国,陆汉明.以坏疽性脓皮病为主要表现的溃疡性结肠炎一例[J].中华消化杂志,2003,23(12):734-734. 被引量:3
  • 9Kaddoura I, Atom C. A rationale for adjuvant surgical intervention in pyoderma gangrenosum. Ann Plast Surg, 2001, 46: 23-28.

二级参考文献6

  • 1Su WP, Davis MD, Weenig RH, et aL Pyoderma gangrenosum:clinicopathologic correlation and proposed diagnostic criteria [J].lnt J Dermatol, 2004, 43(11): 790-800.
  • 2Boh EE. Painful non-healing leg ulcers[J]. J Am Acad Dermatol,2004, 51(5): 847-849.
  • 3Hoffman MD. Pyoderma gangrenosum associated with c-ANCA (h-lamp-2)[J]. Int J Dermatol, 2001, 40(2): 135-137.
  • 4Hagman JH, Carrozzo AM, Campione E, et al. The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum[J]. J Dermatolog Treat, 2001, 12(1): 19-22.
  • 5Dobson CM, Parslew RA, Evans S. Superficial granulomatous pyoderma treated with intravenous immunoglobulin[J]. J Am Acad Dermatol, 2003, 48(3): 456-460.
  • 6顾有守.坏疽性脓皮病的治疗[J].临床皮肤科杂志,1997,26(3):202-204. 被引量:4

共引文献43

同被引文献35

  • 1顾有守.坏疽性脓皮病[J].临床皮肤科杂志,2005,34(10):708-709. 被引量:42
  • 2蒋燕萍,余德厚,何勤,陆洪光.坏疽性脓皮病1例[J].中国皮肤性病学杂志,2007,21(4):236-237. 被引量:3
  • 3赵辨.中国临床皮肤病学.南京:江苏科学技术出版社,2009.
  • 4朱斌,唐冰,朱家源,李新强.创面床准备对糖尿病性溃疡各时期MMP-1活性及胶原合成的的影响[J].南方医科大学学报,2007,27(10):1540-1542. 被引量:14
  • 5Brunsting LA, Goeckerman WH, O'Leary PA. Pyoderma gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syphilol 1930; 22:655-680 [DOI: 10.1001/ archderm.1930.01440160053009].
  • 6Richetta AG, Maiani E, Carboni V, Carlomagno V, Cimillo M, Mattozzi C, Calvieri S. [Pyoderma gangrenosum: case series]. Clin Ter 2007; 158: 325-329 [PMID: 17953284].
  • 7La Marca S, Toussoun G, Ho Quoc C, Sebban H, Delay E. Pyoderma gangrenosum: an exceptional complication of venous access device. ]Vasc Access 2014; 15:321-324 [PMID: 24190068 DOI: 10.5301/jva.5000181].
  • 8Uchino M, Ikeuchi H, Matsuoka H, Bando T, Takahashi Y, Takesue Y, Matsumoto T, Tomita N. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease. Digestion 2012; 85:295-301 [PMID: 22584791 DOI: 10.1159/000336719].
  • 9A1 Ghazal P, Herberger K, Schaller J, StrOlin A, Hoff NP, Goerge T, Roth H, Rabe E, Karrer S, Renner R, Maschke J, Horn T, Hepp J, Eming S, Wollina U, Zutt M, Sick I, Splieth B, Dill D, Klode J, Dissemond J. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis 2013; 8:136 [PMlD: 24010984 DOI: 10.1186/1750-1172-8-136].
  • 10Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005; 53:273-283 [PMID: 16021123 DOI: 10.1016/j.jaad.2004.10.006].

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部